FLT3 and acute myeloid leukemia: Starting from the observation that new compounds with pyrazole amine scaffolds exhibited potent inhibitory activity and selectivity against FLT3-ITD AML cells [89], novel 3-amine-pyrazole-5-benzimidazole compounds were designed and tested in order to overcome secondary resistance mutations [75].